Olivera Jovic, DPM
Foot & Ankle Surgery · Denver, CONPI 1649554882
Payments from drug & device makers
What this record shows
The money is spread across several categories — gifts (49.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Zimmer Biomet at 50.1% of the total. Reporting peaked in 2019 at $5,328 and has fallen 72.1% since, to $1,485 in 2025.
Across 81 payments — averaging $119.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$5K
- Smith+Nephew$2K
- Stryker$1K
- Musculoskeletal Transplant Foundation Inc.$816
- Globus Medical$229
- Paratek Pharmaceuticals, Inc.$197
- plus $806 from 22 others
What the payments were for
- Speaking & faculty fees$240%
- Travel & lodging$1,52616%
- Food & beverage$3,28434%
- Gifts$4,82350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 2 | $4,836 |
| Smith+Nephew | 35 | $1,565 |
| Stryker | 6 | $1,209 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $816 |
| Globus Medical | 1 | $229 |
| Paratek Pharmaceuticals, Inc. | 7 | $197 |
| Medtronic | 1 | $155 |
| Misonix Inc | 2 | $114 |
| Orthofix Medical, Inc. | 2 | $67 |
| Arthrosurface Incorporated | 1 | $48 |
| Integra Lifesciences Corporation | 2 | $42 |
| Bioventus LLC | 2 | $33 |
| Nevro Corp. | 1 | $32 |
| Amgen | 1 | $28 |
| Ossur Americas, Inc. | 1 | $28 |
| Treace Medical Concepts, Inc. | 1 | $25 |
| Solventum Corporation | 1 | $24 |
| Acorda Therapeutics, Inc | 1 | $24 |
| Boston Scientific | 1 | $24 |
| Acera Surgical, Inc. | 1 | $23 |
| Urgo Medical North America, LLC | 1 | $22 |
| Organogenesis Inc. | 1 | $21 |
| Hartmann USA, Inc. | 1 | $21 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Aroa Biosurgery Incorporated | 1 | $18 |
| KCI USA, Inc. | 1 | $14 |
| Convatec Inc. | 1 | $13 |
| Dynasplint Systems Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zimmer Biomet Instruments and Implants$4,823
- SPY-PHI SYSTEM$1,105
- GRAFIX PL$539
- Stravix$386
- Osteocel$229
- HawkOne$155
- STRAVIX PL$122
- NUZYRA$118
- Grafix PL PRIME$112
- Grafix$110
- SonicOne$109
How this compares
$9,658 in reported general payments places this provider in the 75th percentile of 181 foot & ankle surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 42 | $382 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $114 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Denver
- Kevin NagamaniDenver$288K
- Keith JacobsonDenver$241K
- Stephen WallaceDenver$33K
- Marissa JamiesonDenver$30K
- Matthew GorskiDenver$14K
- Eric JaakolaDenver$14K
- Lauren MolchanDenver$10K
- Emma KayalDenver$8K
- Michael HoughtonFort Collins$2M
- Joshua MetzlEnglewood$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.